Myxomatous Mitral Valve Disease (MMVD) in Goldendoodles

Veterinary cardiologists commonly use a staging framework, often labeled B1 through C and D, to describe MMVD progression. Stage B1 means a murmur is present but the heart hasn't yet begun to enlarge in response — many dogs live for years at this stage with no medication needed, just periodic monitoring. Stage B2 means the heart has started to enlarge as it compensates for the leaking valve, which is the point where many cardiologists now recommend starting a specific medication shown to delay progression to heart failure, based on findings from a major veterinary cardiology trial.

Stage C means the dog has developed congestive heart failure, with fluid backing up into the lungs or abdomen, and requires active medical management, typically multiple medications working together to manage fluid and support heart function. Stage D means the disease has progressed to a point where standard treatment is no longer adequately controlling symptoms, requiring more aggressive or specialized management.

Because MMVD progresses gradually and staging is based on specific echocardiogram measurements rather than symptoms alone, a dog can move from B1 to B2 without any obvious change in how it acts day to day, which is exactly why regular cardiology rechecks, not just watching for symptoms at home, are how progression actually gets caught early enough to start treatment at the right stage.

Each stage generally comes with a specific shift in monitoring frequency and treatment intensity.

If you think your Doodle has myxomatous mitral valve disease (mmvd), the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers hip dysplasia, ear infections, allergies.

What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.

Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for myxomatous mitral valve disease (mmvd) it is often what separates a clear pattern from a guess.